Aqueous Selenium and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Aqueous Selenium and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: selenium
Brand name: Selenium TR, Selepen, Sele-Pak
Synonyms: Selenium
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aqueous Selenium-Insulin glargine, recombinant Subcutaneous
- Aqueous Selenium-Insulin glulisine
- Aqueous Selenium-Insulin Glulisine (Cartridges and Pens)
- Aqueous Selenium-Insulin Glulisine (Vials)
- Aqueous Selenium-Insulin glulisine Subcutaneous
- Aqueous Selenium-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Aqueous Vitamin D
- Insulin glargine and lixisenatide Subcutaneous-Aqueous Vitamin E
- Insulin glargine and lixisenatide Subcutaneous-Arakoda
- Insulin glargine and lixisenatide Subcutaneous-Aralen
- Insulin glargine and lixisenatide Subcutaneous-Aralen Phosphate
- Insulin glargine and lixisenatide Subcutaneous-Aranelle